A Phase II Study of Pemetrexed and Carboplatin in the Treatment of Esophageal Cancer
Status:
Terminated
Trial end date:
2010-06-01
Target enrollment:
Participant gender:
Summary
This is a study of an investigational agent, pemetrexed, in combination with a standard
chemotherapy drug, carboplatin, for treatment of patients with metastatic esophageal cancer.